L. , S. Les-adhésines-au-niveau-moléculaire, and .. , 38 b)Les adhésines de type lectine, 39 c)Les adhésines fibrillaires, p.39

.. Différents-mécanismes-de-défense-de-l-'hôte, 43 2.3.1 Immunité non spécifique : réponse innée 44 a) Les polynucléaires neutrophiles (PNN), 46 c) Les cellules Natural Killer........ 46 d) Récepteurs spécifiques de l'immunité non spécifique, p.46

L. , D. La-candidose-atrophique, .. La-candidose-pseudotumorale, .. La-candidose-oesophagienne, and .. , 66 a)Les candidoses oropharyngées 66 b) 67 e)La candidose de la commissure labiale 68 g)La candidose gastro-intestinale, ., vol.68, p.69

L. Candidoses-génito-urinaires, .. , and C. , 69 5.1.2.1 La vulvo-vaginite à, p.72

.. Microscopie:-examen-direct, 79 a)Milieux standards 79 b)Milieux spéciaux, p.80

E. Candida and A. , 83 a) 84 b)Recherche de chlamydospores 84 c)Test d'identification rapide, Milieux spéciaux, p.85

A. Espèces-non and .. Sensibilité-au-cycloheximide, 86 a) 86 b), 86 c)Zymogramme ou test de fermentation

.. Traitements-des-candidoses-cutanéo-muqueuses, 90 7.1Les mécanismes d'action des antifongiques Les molécules inhibant la synthèse de l'ergostérol, p.94

L. and G. International, AMM 1992) : solution filmogène pour application locale à 5 %, pp.5-29

. Mais, les nombreuses interactions complexes entre l'amphotéricine B et la membrane des cellules fongiques peuvent expliquer la faible apparition de résistance

L. Antifongigramme and . Permet-de-déterminer, vitro la sensibilité aux antifongiques des souches isolées d'un prélèvement donné Ce test est justifié du fait de la résistance confirmée de certaines espèces aux antifongiques mais il ne doit pas être considéré comme un examen systématique Ainsi dans les candidoses superficielles, ce test ne sera utilisé que sur des lésions récidivantes pour lesquelles on soupçonne une résistance au traitement. Avant tout, il faudra s'assurer que le traitement est été suffisamment et correctement suivi

. Aujourd-'hui, de nombreuses spécialités sont proposées pour la toilette intime

A. I. Noel-t, Antifungals cellular targets and mechanisms of resistance, Therapie, vol.61, pp.195-199, 2006.

A. S. Beltron-c, S. P. Aguirre-i, M. F. Peralta-a, and . Hermoso-m, Toll-like Receptors are Key Participants in Innate Immune Responses, Biol Res, vol.40, pp.97-112, 2007.

A. R. Farah-c, Oral candidiasis: Clinical Manifestatons and Cellular Adaptive Host Response, Fungal immunol, vol.4, pp.59-83, 2005.

B. R. Johnson-a, Completion of a parasexual cycle in Candida albicans by induced chromosome loss in tetraploid strains

B. R. Johnson-a, Mating in Candida albicans and the search for a sexual cycle, Annu Rev Microbiol, vol.59, pp.233-255, 2005.

B. B. Van-het-hoog, . Martchenko-m, and . Dungan-j, A Human-curated annotation of the Candida albicans genome, Plos genetics, vol.1, pp.36-57, 2005.

C. J. and L. S. Fernandez-c, Pharmacie clinique et thérapeutique, pp.1094-1123, 2008.

C. A. De and B. F. Santoni-g, Anticandidal Immunity and Vaginitis: Novel Opportunities for Immune Intervention, Inf Imm, vol.75, pp.4675-4686, 2007.

C. A. and N. D. Horn-d, Candidemia in 21 th century, Future Microbiology, vol.3, pp.463-472, 2008.

C. Rachel and L. Md, Prevention and treatment of Candida infections in Neonates, Seminars in Perinatology, vol.31, pp.39-46, 2007.

C. N. , L. D. Singh-p, and C. R. , The cell wall of Candida spp in Candida and Candidiasis, 2002.

C. S. , C. C. , C. M. Handfield-m, . Hillman-j, . A. Progulske-fox et al., Identification of Candida albicans genes induced during thrush offers insight into pathogenesis, Mol Microbiol, vol.48, pp.1275-1288, 2003.

D. M. Service-de-parasitologie-mycologie, C. C. Dupuytren-limoges-24.-d-'enfert, and . Hube-b, Candida: comparative and functional genomics, 2007.

D. R. Mandell and G. L. , Atlas des maladies infectieuses: infections fongiques, Edition CURRENT MEDECINE Philapdelphia, pp.118-133, 2001.

D. D. Messer-s and . Brueggemann-a, Epidemiology of Candidemia: 3-year results from emerging Infections and the epidemiology of Iowa Organisms Study

D. C. Schandar-m, J. F. Noll-m, . Brunner-h, . Graeve-t, and . Rupp-s, In vitro reconstructed human epithelia reveal contributions of Candida albicans EFG1 and CPH1 to adhesion and invasion, Microbiol, vol.148, pp.497-506, 2002.

D. G. , K. A. , S. G. , and F. Mf, Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study

E. S. Pang-g, . Ashman-r, and . Clancy-r, Enhanced clearance of Candida albicans from the oral cavities of mice following oral administration of Lactobacillus acidophilus, Clin Exp Immunol, vol.41, pp.29-36, 2005.

G. H. , G. S. Copolillo-e, C. E. Barata-a, . Vay-c, . De-torres-r et al., Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents, Rev Argent Microbiol, vol.38, pp.9-12, 2006.

G. Ah, Posaconazole for paediatrics patients: status of development and future perspectives, Mycoses, vol.51, pp.5-11, 2008.

H. K. , A. A. Yli-knuuttila, . Richardson-m, M. J. Poussa-t, and . Korpela-r, Probiotics Reduce the Prevalence of Oral Candida in the Ederly-a Randomized Controlled Trial, J Dent Res, vol.86, pp.125-130, 2007.

L. Jp and . Sotto-a, Les candiduries, Prog Uro, vol.15, pp.213-216, 2005.

L. E. , H. D. , D. D. , J. L. , U. S. et al., Ras links cellular morphogenesis to virulence by regulation of the MAP kinase and AMPc signalling pathways in the pathogenic fungus Candida albicans, Mol Microbiol, vol.42, pp.673-687, 2001.

M. Cm and G. Rf, Antifungal drug resistance to azoles and polyenes, The Lancet Infect Dis, vol.2, pp.550-63, 2002.

M. M. Johnson-a, White-Opaque switching in Candida albicans is controlled by mating type locus homeodomain proteins and allows efficient mating, Cell, vol.110, pp.293-302, 2002.

M. R. and R. E. Nombela-c, The MAP kinase signal transduction nework in Candida albicans, Microbiol, vol.152, pp.905-912, 2006.

N. Mg, . Brown-gd, and . Kullberg-bj, An integrated model of the recognition of Candida albicans by the innate immune system, Nat Rev Microbiol, vol.6, pp.67-78, 2008.

R. H. , A. A. , R. P. De-champ-c, and E. Y. , Candidemia in french hospitals: incidence rates and characteristics, Clin Microbiol Infect, vol.8, pp.405-412, 2002.

R. P. Vermistsky-jp and H. D. Edlind-t, Proteomic analysis of experimentally induced azole resistance in Candida glabrata

J. L. Rowen and . Candidiasis, Mucocutaneous candidiasis, Seminars in Perinatology, vol.27, issue.5, pp.406-413, 2003.
DOI : 10.1016/S0146-0005(03)00066-1

R. , E. M. , and V. E. Sentandreu-r, Molecular organization of the cell wall of Candida albicans and its relation to pathogenicity, FEMS Yeast Res, vol.6, pp.14-29, 2006.

S. D. Ischer-f, . Parkinson-t, and . Falconer-d, Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents, Antimicrob Agents Chemother, vol.47, pp.2404-2416, 2003.

S. D. and O. Fc, Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences, The Lancet Infect Dis, vol.2, pp.73-85, 2002.

S. M. Boeld-u, O. S. Hamm-g, and . Hube-b, Polymorphonuclear leukocytes (PMNs) induce protective, Th1-type cytokine epithelial responses in an in vitro model of oral candidosis, Microbiol, vol.150, pp.2807-2813, 2004.

S. B. , C. A. , F. N. D-'haveloose, C. D. Standaert-a, and . Poulain-d, Candidemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links, BMC Infect Dis, vol.6, pp.1-9, 2006.

S. Jd, . Wiensenfeld-hc, and . Martens-m, Maintenance fuconazole therapy for recurrent vulvovaginal candidiasis, N Engl J Med, vol.351, pp.876-83, 2004.

S. D. Lockhart-s and . Zhao-r, Relationship between Switching and Mating in Candida albicans, Eukaryotic Cell, vol.2, pp.390-397, 2003.

S. S. Wagner-dk and . Sohnie-pg, Immunology of Cutaneus Candidiasis, Fungal Immunol, vol.21, pp.421-442, 2005.

S. P. Gow-n and . Berman, The distinct morphogenic states of Candida albicans, Trends Microbiol rev, vol.12, pp.317-324, 2004.

S. D. Moran-g, . Pinjon-e, . A. Al-mosaid, . Stokes-c, . Vaugan-c et al., Comparison of the epidemiology, drug resistance mechanisms and virulence of Candida albicans and Candida dubliniensis, FEMS Yeast Res, vol.4, pp.369-376, 2004.

T. M. La-collaboration-de and D. Labayle, Guide de pharmacologie, Edition LAMARRE, pp.795-811, 2003.

T. Am, P. J. Bernhardt-h, . Klingspor-l, . Kibbler-cc, . Faure-o et al., Epidemiology of candidemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study

V. Ja and S. Jd, Mucosal candidiasis, Infect Dis Clin North Am, vol.16, pp.793-820, 2002.

Z. T. , A. J. , J. Chu, J. A. Berlin, T. J. Walsh et al., The epidemiology and Attributable Outcomes of Candidemia in Adults an Children Hospitalized in the United States: a Propensity Analysis, Clin Infect Dis, vol.41, pp.1232-1239, 2005.

Z. X. , O. S. Cheng-g, N. J. Green-c, Y. K. , L. R. Brown-a et al., ALS3 and ALS8 represent a single locus that encodes a Candida albicans adhesin: functional comparisons between Als3p and Als1p, Microbiol, vol.150, pp.2415-2428, 2004.

Z. X. , O. S. , and Y. K. Hoyer-l, Analysis of Candida albicans Als2p and Als4p adhesins suggests the potential for compensatory function within the Als family, Microbiol, vol.151, pp.1619-1630, 2005.